Cleared Special

K191635 - Optilite IgM Kit (FDA 510(k) Clearance)

Jul 2019
Decision
26d
Days
Class 2
Risk

K191635 is an FDA 510(k) clearance for the Optilite IgM Kit. This device is classified as a Method, Nephelometric, Immunoglobulins (g, A, M) (Class II - Special Controls, product code CFN).

Submitted by The Binding Site Group , Ltd. (Edgbaston, GB). The FDA issued a Cleared decision on July 15, 2019, 26 days after receiving the submission on June 19, 2019.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5510.

Submission Details

510(k) Number K191635 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 19, 2019
Decision Date July 15, 2019
Days to Decision 26 days
Submission Type Special
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code CFN — Method, Nephelometric, Immunoglobulins (g, A, M)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5510